SG Americas Securities
NAUT icon

SG Americas Securities’s Nautilus Biotechnolgy NAUT Stock Holding History

SG Americas Securities’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,034
Closed -$22K – 3361
2025
Q1 		$22K Sell
26,034
-1,449
-5% -$2.15K ﹤0.01% 3371
2024
Q4 		$46K Buy
27,483
+9,904
+56% +$23.7K ﹤0.01% 2919
2024
Q3 		$50K Buy
+17,579
New +$45.5K ﹤0.01% 3249
2024
Q2 		– Sell
-20,209
Closed -$59K – 3145
2024
Q1 		$59K Sell
20,209
-8,397
-29% -$23.8K ﹤0.01% 2714
2023
Q4 		$86K Buy
28,606
+6,234
+28% +$17.8K ﹤0.01% 2811
2023
Q3 		$71K Buy
+22,372
New +$72.8K ﹤0.01% 2873
2023
Q2 		– Sell
-20,810
Closed -$58K – 2860
2023
Q1 		$58K Buy
20,810
+2,527
+14% +$5.3K ﹤0.01% 3044
2022
Q4 		$33K Buy
18,283
+462
+3% +$892 ﹤0.01% 2888
2022
Q3 		$38K Sell
17,821
-1,386
-7% -$3.49K ﹤0.01% 3032
2022
Q2 		$52K Buy
+19,207
New +$71.5K ﹤0.01% 3255

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

SG Americas Securities's NAUT Position: Q2 2025 in Review

SG Americas Securities sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 26,034 shares — an estimated $22K sold.

SG Americas Securities first reported a position in NAUT in Q2 2022 and held it in 10 quarters. The position peaked at $86K in Q4 2023. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • SG Americas Securities reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 26,034 Nautilus Biotechnolgy shares in Q2 2025, an estimated $22K.
  • SG Americas Securities first reported a position in Nautilus Biotechnolgy in Q2 2022 and held it in 10 quarters.
  • SG Americas Securities's Nautilus Biotechnolgy position peaked at $86K in Q4 2023.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.